Patents by Inventor Peter-Paul L.I. Platenburg

Peter-Paul L.I. Platenburg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Adjuvants
    Patent number: 10342867
    Abstract: The present invention relates to a family of carbohydrate monosulphate fatty acid esters, which contain less than 10 mole % of carbohydrate polysulphate fatty acid esters, and to a method of preparation thereof. The monosulphate carbohydrate esters according to the invention comprise one sulphate ester and at least one fatty acid and are among others useful as adjuvants for immunological products such as vaccines.
    Type: Grant
    Filed: July 24, 2015
    Date of Patent: July 9, 2019
    Assignee: LITEVAX B.V.
    Inventors: Lucas A. Th. Hilgers, Peter Paul L. I. Platenburg, Johannes F. Van Den Bosch
  • ADJUVANTS
    Publication number: 20170209568
    Abstract: The present invention relates to a family of carbohydrate monosulphate fatty acid esters, which contain less than 10 mole % of carbohydrate polysulphate fatty acid esters, and to a method of preparation thereof. The monosulphate carbohydrate esters according to the invention comprise one sulphate ester and at least one fatty acid and are among others useful as adjuvants for immunological products such as vaccines.
    Type: Application
    Filed: July 24, 2015
    Publication date: July 27, 2017
    Applicant: LiteVax B.V.
    Inventors: Lucas A. Th. HILGERS, Peter Paul L. I. PLATENBURG, Johannes F. VAN DEN BOSCH
  • Adjuvant composition containing synthetic hydrophobic lipopolysaccharide
    Patent number: 5976538
    Abstract: According to the present invention the adjuvants comprise an emulsion containing at least one synthetic hydrophobic lipopolysaccharide, which can either or not be provided with anionic groups, while maintaining the overall hydrophobicity, an interface-forming constituent (such as an oil) and optionally an aqueous solute. In particular the adjuvant and vaccines prepared with it contain a lipopolysaccharide which had an HLB value of less then 9, more favorably less than 4.
    Type: Grant
    Filed: November 15, 1996
    Date of Patent: November 2, 1999
    Assignee: American Cyanamid Company
    Inventors: Lucas A.T. Hilgers, Peter-Paul L.I. Platenburg